FIELD: medicine.
SUBSTANCE: invention relates to the use of Prostatilen AC in male rats of reproductive age as a cancer-preventive agent against testicular cancer and hereditary cancer.
EFFECT: proposed solution enables to use the preparation Prostatilen AC as a cancer preventive agent for testicular tissue cells and sperm cells.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT WHICH REDUCES GENOTOXICITY LEVEL OF CYTOSTATICS | 2018 |
|
RU2697524C1 |
METHOD FOR LABORATORY DIAGNOSIS OF MALE REPRODUCTIVE FUNCTION BASED ON EVALUATION OF SPERMATOZOA DNA FRAGMENT DISPERSION | 2022 |
|
RU2795567C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING REPRODUCTIVE AND ERECTILE DYSFUNCTIONS IN MEN AND USE THEREOF | 2023 |
|
RU2825382C1 |
METHOD FOR CORRECTION OF HYPOGONADISM IN ANIMALS DURING SIMULATION OF ACUTE INJURY OF SPINAL CORD | 2017 |
|
RU2689114C2 |
MEDICINAL AGENT FOR CANCER PREVENTION | 2006 |
|
RU2328294C1 |
BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT FOR STIMULATING TISSUE REGENERATION AND RECOVERY OF DIMINISHED TISSUE FUNCTION | 2015 |
|
RU2647438C2 |
BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT STIMULATING TISSUE REGENERATION AND RESTORATION OF REDUCED FUNCTIONS OF TISSUES | 2016 |
|
RU2727142C2 |
AGENT FOR CANCER PROPHYLAXIS | 2005 |
|
RU2290178C1 |
METHOD FOR CREATING ORTHOTOPIC ENDOMETRIAL CANCER MODEL | 2024 |
|
RU2818464C1 |
METHOD FOR EPITHELIAL MESENCHYMAL TRANSFORMATION OF TUMOUR EPITHELIUM DURING EXPERIMENTAL GASTRIC CANCER | 2016 |
|
RU2626717C1 |
Authors
Dates
2024-06-05—Published
2023-07-12—Filed